Cargando…

What is the added value of digital image analysis of HER2 immunohistochemistry in breast cancer in clinical practice? A study with multiple platforms

AIMS: We aimed to compare digital image analysis (DIA) of human epidermal growth factor receptor 2 (HER2) immunohistochemistry (IHC) in breast cancer by two platforms: (i) to validate DIA against standard diagnostics; and (ii) to evaluate the added value of DIA in clinical practice. METHODS AND RESU...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koopman, Timco, Buikema, Henk J, Hollema, Harry, de Bock, Geertruida H, van der Vegt, Bert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850320/ https://www.ncbi.nlm.nih.gov/pubmed/30585668 http://dx.doi.org/10.1111/his.13812

Ejemplares similares

Digital image analysis of Ki67 proliferation index in breast cancer using virtual dual staining on whole tissue sections: clinical validation and inter-platform agreement
por: Koopman, Timco, et al.
Publicado: (2018)

Is HER2 amplification predictable by digital immunohistochemistry?
por: Micsik, Tamás, et al.
Publicado: (2013)

Pain evaluation during gynaecological surveillance in women with Lynch syndrome
por: Helder-Woolderink, Jorien, et al.
Publicado: (2016)

Pathological and Biological Differences Between Screen-Detected and Interval Ductal Carcinoma in situ of the Breast
por: de Roos, Marnix A., et al.
Publicado: (2007)

Diet quality indices and gastrointestinal cancer risk: results from the Lifelines study
por: Moazzen, Sara, et al.
Publicado: (2021)

The natural history of ductal carcinoma in situ (DCIS) in simulation models: A systematic review
por: Poelhekken, Keris, et al.
Publicado: (2023)

Digital image analysis of intraepithelial B-lymphocytes to assess lymphoepithelial lesions in salivary glands of Sjögren’s syndrome patients
por: van Ginkel, Martha S, et al.
Publicado: (2022)

Association of homozygous variants of STING1 with outcome in human cervical cancer
por: Lubbers, Joyce M., et al.
Publicado: (2020)

The Effect of Risk-Reducing Salpingo-Oophorectomy on Breast Cancer Incidence and Histopathological Features in Women with a BRCA1 or BRCA2 Germline Pathogenic Variant
por: Stuursma, Annechien, et al.
Publicado: (2023)

Prediction of Incident Cancers in the Lifelines Population-Based Cohort
por: Cortés-Ibañez, Francisco O., et al.
Publicado: (2021)

Feasibility of endometrial sampling by vaginal tampons in women with Lynch syndrome
por: Woolderink, Jorien M., et al.
Publicado: (2020)

Diagnostic accuracy of bronchial brush cytology and the added value of immunohistochemistry and fluorescence in situ hybridization of pulmonary neuroendocrine tumors
por: Reynolds, Jordan P., et al.
Publicado: (2014)

What is the added value of FeNO as T2 biomarker?
por: Marcos, María Celeste, et al.
Publicado: (2022)

Added Value of HER-2 Amplification Testing by Multiplex Ligation-Dependent Probe Amplification in Invasive Breast Cancer
por: Kuijpers, Chantal C. H. J., et al.
Publicado: (2013)

Digital immunohistochemistry platform for the staining variation monitoring based on integration of image and statistical analyses with laboratory information system
por: Laurinaviciene, Aida, et al.
Publicado: (2014)

Effectiveness of Organized Mammography Screening for Different Breast Cancer Molecular Subtypes
por: Ding, Lilu, et al.
Publicado: (2022)

HER2 amplification by next-generation sequencing to identify HER2-positive invasive breast cancer with negative HER2 immunohistochemistry
por: Morsberger, Laura, et al.
Publicado: (2022)

Biological tumor markers associated with local control after primary radiotherapy in laryngeal cancer: A systematic review
por: Noordhuis, Maartje G., et al.
Publicado: (2020)

Tendering and biosimilars: what role for value-added services?
por: Simoens, Steven, et al.
Publicado: (2019)

Rapid BRAF mutation tests in patients with advanced melanoma: comparison of immunohistochemistry, Droplet Digital PCR, and the Idylla Mutation Platform
por: Bisschop, Cornelis, et al.
Publicado: (2018)

HER-2 Expression in Immunohistochemistry Has No Prognostic Significance in Gastric Cancer Patients
por: Halon, Agnieszka, et al.
Publicado: (2012)

Comparison of HER2 status by fluorescence in situ hybridisation and immunohistochemistry in gastric cancer
por: Chen, Ming, et al.
Publicado: (2014)

Immunohistochemistry and alternative FISH testing in breast cancer with HER2 equivocal amplification
por: Agersborg, Sally, et al.
Publicado: (2018)

Standardised Ki‐67 proliferation index assessment in early‐stage laryngeal squamous cell carcinoma in relation to local control and survival after primary radiotherapy
por: Kop, Emiel, et al.
Publicado: (2019)

Value added medicines: what value repurposed medicines might bring to society?
por: Toumi, Mondher, et al.
Publicado: (2016)

Pathologic complete response to neoadjuvant anti-HER2 therapy is associated with HER2 immunohistochemistry score in HER2-positive early breast cancer
por: Chen, Hai-long, et al.
Publicado: (2021)

What counts in teaching mathematics: adding value to self and content
por: Schuck, Sandy, et al.
Publicado: (2011)

Detection of Her-2/neu expression in gastric cancer: Quantitative PCR versus immunohistochemistry
por: ZHU, GUANG-JUN, et al.
Publicado: (2014)

FISH testing of HER2 immunohistochemistry 1+ invasive breast cancer with unfavorable characteristics
por: Petroni, Stella, et al.
Publicado: (2016)

The Added Value of Musculoskeletal Simulation for the Study of Physical Performance in Military Tasks
por: Kessels, Ilona, et al.
Publicado: (2021)

A nomogram to predict HER2 status in breast cancer patients with HER2-borderline disease as determined via immunohistochemistry
por: Guo, Qianqian, et al.
Publicado: (2017)

Droplet digital polymerase chain reaction offers an improvisation over conventional immunohistochemistry and fluorescent in situ hybridization for ascertaining Her2 status of breast cancer
por: Suryavanshi, Moushumi, et al.
Publicado: (2019)

Evaluating Low HER2 Status in Invasive Breast Carcinoma via HER2 Immunohistochemistry, with HER2 FISH Correlation: A Cohort of 112 Patients
por: Ardor, Gokce Deniz, et al.
Publicado: (2023)

Are There More HER2 FISH in the Sea? An Institution’s Experience in Identifying HER2 Positivity Using Fluorescent In Situ Hybridization in Patients with HER2 Negative Immunohistochemistry
por: Suydam, Camille, et al.
Publicado: (2023)

Breast Cancer Diagnosis Using a Microfluidic Multiplexed Immunohistochemistry Platform
por: Kim, Minseok S., et al.
Publicado: (2010)

Comparing the Cervista HPV HR Test and Hybrid Capture 2 Assay in a Dutch Screening Population: Improved Specificity of the Cervista HPV HR Test by Changing the Cut-Off
por: Boers, Aniek, et al.
Publicado: (2014)

Value of immunohistochemistry in the diagnosis of malignant cervical lymph nodes
por: de Natale Caly, Décio, et al.
Publicado: (2015)

Potential Target Antigens for a Universal Vaccine in Epithelial Ovarian Cancer
por: Vermeij, Renee, et al.
Publicado: (2010)

Distinct Biomarker Profiles and Clinical Characteristics in T1‐T2 Glottic and Supraglottic Carcinomas
por: Wachters, Jan E., et al.
Publicado: (2020)

Impact of health-related behavioral factors on participation in a cervical cancer screening program: the lifelines population-based cohort
por: Castañeda, Kelly M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2j0j3k15bs0nsumnq42qclc51a